PYXS vs VNO · rev $2.8M vs rev $921.3M
Pyxis Oncology Inc (PYXS) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
VNO (VNO) common stock.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
PYXS currently screens at market cap $109.6M. VNO currently screens at market cap $0.
Not investment advice. Open the PYXS and VNO stock pages for the full models.
Not investment advice.